The effect of polymorphisms of MTHFR C677T, A1298C, MS A2756G and CBS 844ins68bp on plasma total homocysteine level and the risk of ischemic stroke in Thai children

Thrombosis Research

Volumn 122, Issue 1, 2008, Pages 33-37

  Sirachainan, Nongnuch ^a   Sasanakul, Werasak ^a   Visudtibhan, Anannit ^a   Tapanapruksakul, Pornsri ^a   Charoenkwan, Pimlak ^b   Kadegasem, Praguywan ^a   Udomsubpayakul, Umaporn ^a   Chuansumrit, Ampaiwan ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

A1298C; CBS 844ins68bp; Children; Homocysteine; Ischemic stroke; MS A2756G; MTHFR C677T

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HEREDITY; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GENE FREQUENCY; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTAGENESIS, INSERTIONAL; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; STROKE; THAILAND;

EID: 42649095999     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.09.012     Document Type: Article

References (31)

1. Kosch A.K., Koch H.G., Heinecke A., Kurnik K., Heller C., Nowak-Gottl U., and Childhood Thrombophilia Study Group. Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children. Thromb Haemost 91 2 (2004) 308-314
2. van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 62 5 (1998) 1044-1051
3. Lee R., and Frenkel E.P. Hyperhomocysteinemia and thrombosis. Hematol Oncol Clin North Am 17 1 (2003) 85-102
4. Ray J.G. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 158 19 (1998) 2101-2106
5. Li Z., Sun L., Zhang H., Liao Y., Wang D., Zhao B., et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke 34 9 (2003) 2085-2090
6. van Beynum I.M., Smeitink J.A., den Heijer M., te Poele Pothoff M.T., and Blom H.J. Hyperhomocysteinemia: a risk factor for ischemic stroke in children. Circulation 99 16 (1999) 2070-2072
7. Moller J., Nielsen G.M., Tvedegaard K.C., Andersen N.T., and Jorgensen P.E. A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest 60 6 (2000) 491-499
8. Sirachainan N., Tapanapruksakul P., Visudtibhan A., Chuansumrit A., Cheeramakara C., Atamasirikul K., et al. Homocysteine, MTHFR C677 T, vitamin B12, and folate levels in Thai children with ischemic stroke: a case-control study. J Pediatr Hematol/Oncol 28 12 (2006) 803-808
9. Tan N.C., Venketasubramanian N., Saw S.M., and Tjia H.T. Hyperhomocyst(e) inemia and risk of ischemic stroke among young Asian adults. Stroke 33 8 (2002) 1956-1962
10. Lentz S.R. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 3 8 (2005) 1646-1654
11. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 1 (1995) 111-113
12. Kluijtmans L.A., van den Heuvel L.P., Boers G.H., Frosst P., Stevens E.M., van Oost B.A., et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 58 1 (1996) 35-41
13. Kluijtmans L.A., Kastelein J.J., Lindemans J., Boers G.H., Heil S.G., Bruschke A.V., et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 96 8 (1997) 2573-2577
14. Morita H., Taguchi J., Kurihara H., Kitaoka M., Kaneda H., Kurihara Y., et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95 8 (1997) 2032-2036
15. Brattstrom L., Wilcken D.E., Ohrvik J., and Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 98 23 (1998) 2520-2526
16. Deloughery T.G., Evans A., Sadeghi A., McWilliams J., Henner W.D., Taylor Jr. L.M., et al. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation 94 12 (1996) 3074-3078
17. van Bockxmeer F.M., Mamotte C.D., Vasikaran S.D., and Taylor R.R. Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation 95 1 (1997) 21-23
18. Zhang G., and Dai C. Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. Thromb Res 104 3 (2001) 187-195
19. Kan Y.W., Dozy A.M., Trecartin R., and Todd D. Identification of a nondeletion defect in alpha-thalassemia. N Engl J Med 297 20 (1977) 1081-1084
20. Leclerc D., Campeau E., Goyette P., Adjalla C.E., Christensen B., Ross M., et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 5 12 (1996) 1867-1874
21. Zhang Y.D., Ke X.Y., Shen W., and Liu Y. Relationship of homocysteine and gene polymorphisms of its related metabolic enzymes with Alzheimer's disease. Chin Med Sci J 20 4 (2005) 247-251
22. Akar N., Akar E., Ozel D., Deda G., and Sipahi T. Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res 102 2 (2001) 115-120
23. Nowak-Gottl U., Strater R., Heinecke A., Junker R., Koch H.G., Schuierer G., et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 94 11 (1999) 3678-3682
24. Zheng Y.Z., Tong J., Do X.P., Pu X.Q., and Zhou B.T. Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population. Br J Haematol 109 4 (2000) 870-874
25. Pezzini A., Del Zotto E., Archetti S., Negrini R., Bani P., Albertini A., et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 33 3 (2002) 664-669
26. Morita H., Kurihara H., Sugiyama T., Hamada C., Kurihara Y., Shindo T., et al. Polymorphism of the methionine synthase gene association with homocysteine metabolism and late-onset vascular diseases in the Japanese population. Arterioscler Thromb Vasc Biol 19 2 (1999) 298-302
27. Kenet G., Sadetzki S., Murad H., Martinowitz U., Rosenberg N., Gitel S., et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 31 6 (2000) 1283-1288
28. Hanson N.Q., Aras O., Yang F., and Tsai M.Y. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem 47 4 (2001) 661-666
29. Botto L.D., and Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151 9 (2000) 862-877
30. Sharp L., and Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 159 5 (2004) 423-443
31. Robien K., and Ulrich C.M. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 157 7 (2003) 571-582